Genetic News

A combination therapy of gemcitabine, capecitabine and bevacizumab improves outcomes in patients with advanced pancreatic cancer, according to a multi-center study led by researchers at Roswell Park Cancer Institute in Buffalo, N.Y. Read the rest of this entry »

Colon cancer patients who have the normal version of a particular gene are more likely to benefit from a combination treatment that includes adding the targeted therapy Erbitux to chemotherapy. Read the rest of this entry »

Drugs used widely to treat anemia in cancer patients may actually speed progression of the cancer in certain individuals, but researchers report they may found a way to determine who those individuals are. Read the rest of this entry »

Chemotherapy may be more effective on melanoma tumors if a protein frequently found in the growth can first be disabled, a new study reports. Read the rest of this entry »

Patients diagnosed with pancreatic cancer - which historically carries a grim prognosis - nearly doubled their overall survival when the cancer drug Gemzar was used after surgery, new research shows. Read the rest of this entry »

A widely prescribed pain reliever may one day have value in helping to prevent lung cancer. Read the rest of this entry »

The long-awaited results of a trial of the biologic drug Erbitux on patients with advanced non-small cell lung cancer show it prolonged survival by about five weeks when combined with chemotherapy. Read the rest of this entry »

Two of the more common and unpleasant side effects of treatment for head and neck cancer patients may be relieved by the ancient Chinese practice of acupuncture. Read the rest of this entry »

People who survived Hodgkin lymphoma as children have an increased risk of developing and dying from another cancer or cardiovascular disease as adults, according to a new report. Read the rest of this entry »

Adding the drug Avastin to chemotherapy lengthened progression-free survival in women with advanced breast cancer, new research shows. Read the rest of this entry »

Chemotherapy may reduce fertility in breast cancer survivors, according to a study led by researchers at Boston’s Dana-Farber Cancer Institute. Read the rest of this entry »